YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Novonesis (Novozymes A/S) Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities The acquisition adds advanced yeast-breeding expertise with a proven track record in bioethanol and broader potential across ind…
Investment increases production capacity, supports booming consumer demand and reinforces Wisconsin's leadership in dairy biosolutions West Allis Ribbon CuttingAnders Lund, Chief Operating Officer and Executive Vice President at Novonesis…
Expansion in Patalganga puts Novozymes under the spotlight Novozymes (CPSE:NSIS B) has come into focus after Novonesis announced a €600 million plan to expand its Patalganga site, with the aim of increasing biosolutions capacity for custom…
Novonesis (Novozymes A/S) Today, Novonesis will initiate the first tranche (the "First Tranche") of the EUR 1 billion multi-year share buyback program announced in Company Announcement No. 14, on August 19, 2026. Under the First Tranche, N…
Novonesis (Novozymes A/S) Novonesis will invest €600 million to expand its site in Patalganga and build a state-of-the-art facility. This marks another step in the company's long-term growth strategy and continued investment in its global…
This article first appeared on GuruFocus. Assessing the Sustainability and Growth of NVZMY's Upcoming Dividend Payment Novonesis (Novozymes) B (NVZMY) recently announced a total dividend of $0.37 per share, with the ex-dividend date set fo…
New Nebraska biotechnology program and scholarship build on education and workforce partnerships across Novonesis' U.S. communities Production OperatorThein Win, Production Operator at Novonesis' Blair biomanufacturing facility Student Tou…
Investors looking for stocks in the Chemical - Specialty sector might want to consider either H. B. Fuller (FUL) or Novozymes A/S (NVZMY). But which of these two stocks is more attractive to value investors? We'll need to take a closer loo…
This article first appeared on GuruFocus. Organic Sales Growth: 8% in H1 2026, with a negative effect of around 1.5 percentage points from exiting certain countries. Adjusted EBITDA Margin: 37.7% in H1 2026, up from 37.4% last year. Adjust…
* Novozymes A/S press release [https://backend.novonesis.com/sites/default/files/document/2026-08/2026-H1-Interim-report.pdf] (NVZMF [https://seekingalpha.com/symbol/NVZMF]): Q2 Non-GAAP EPS of €0.52. * Revenue of €1.12B (+9.8% Y/Y). * Str…
Novonesis (Novozymes A/S) COPENHAGEN, Denmark, August 12, 2026 – Novonesis today announced the launch of Optiva® Triticum, a new biosolution that helps pasta manufacturers increase flexibility in wheat sourcing while maintaining the textur…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Microbial Biostimulants Market size & share revenue was valued at approximately USD 5…
Novonesis (Novozymes A/S) Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities COPENHAGEN, Denmark, August 10 – Novonesis has signed an agreement with the intent to acquire MicroBioGen, an Australian biotech…
Investors interested in Chemical - Specialty stocks are likely familiar with H. B. Fuller (FUL) and Novozymes A/S (NVZMY). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a cl…
Investors interested in Chemical - Specialty stocks are likely familiar with H. B. Fuller (FUL) and Novozymes A/S (NVZMY). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. T…
Investors looking for stocks in the Chemical - Specialty sector might want to consider either H. B. Fuller (FUL) or Novozymes A/S (NVZMY). But which of these two stocks offers value investors a better bang for their buck right now? We'll n…
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Novozymes (CPSE:NSIS B) has drawn investor attention after recent share price moves, with the stock down about 5% year…
Corbion The annual Corbion General Shareholders Meeting held on 13 May 2026 approved the appointments of Per Falholt and Bob Elfring as members of the Supervisory Board. Per Falholt brings over 40 years of experience in research and develo…
Novonesis (Novozymes A/S) COPENHAGEN, Denmark – May 5, 2026. In the first quarter of 2026, Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.8%. Ester Baiget, President & CEO: “The year started stron…
Novonesis (Novozymes A/S) Strong start to the year with 7% organic sales growth and 37.8% adjusted EBITDA margin Ester Baiget, President & CEO:” The year started strong with 7% organic sales growth against a high comparable. We delivered g…
Investors interested in Chemical - Specialty stocks are likely familiar with H. B. Fuller (FUL) and Novozymes A/S (NVZMY). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer lo…
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Novozymes (CPSE:NSIS B) has approved a higher ordinary dividend at…
Investors looking for stocks in the Chemical - Specialty sector might want to consider either H. B. Fuller (FUL) or Novozymes A/S (NVZMY). But which of these two stocks is more attractive to value investors? We'll need to take a closer loo…
Novonesis (Novozymes A/S) Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: Approval of the audited Annual Report for 2025 Approval of distribution of profit with payment of…
Novonesis (Novozymes A/S) COPENHAGEN, Denmark – March 16, 2026. Novonesis has completed a EUR 1.7 billion bond issuance, with significant interest from a broad group of investors. The transaction was primarily undertaken to refinance the b…
As earnings season winds down, investors are shifting focus to updated quant ratings following the latest wave of corporate results. The scores offer a snapshot of how companies rank across key factors such as valuation, growth, profitabil…
Novonesis (Novozymes A/S) On March 12, 2026, Novonesis, through Novozymes A/S, successfully priced and closed an aggregate principal amount of EUR 1.7 billion senior unsecured notes (the "Notes"). The issuance was completed under the newly…
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Novozymes (CPSE:NSIS B) has proposed an amendment to its bylaws that would limit where shareholder general meetings can be h…
Employee PhotoNovonesis employees gathered at the Franklinton, North Carolina site during Manufacturing Day 2025.·GlobeNewswire Inc. Franklinton, North Carolina, March 09, 2026 (GLOBE NEWSWIRE) -- Novonesis, a global leader in biosolutions…
Novonesis (Novozymes A/S) The Annual General Meeting of Novonesis (Novozymes A/S) will be held on Monday March 23, 2026 at 4:00 pm CET at Gammel Venlighedsvej 14, DK-2970 Hoersholm, Denmark. There will also be access to the meeting from th…
Novonesis (Novozymes A/S) COPENHAGEN, Denmark – February 26, 2026. Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.1% in 2025. The company expects a good start to 2026 and a good year overall. Este…
Novonesis (Novozymes A/S) Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.1% in 2025. The company expects a good start to 2026 and a good year overall. Ester Baiget, President & CEO:”In 2025, we co…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. If you are wondering whether Novozymes at a last close of 400.0 is offering good value right now,…
Precedence Research The market continues to expand rapidly, with leading players achieving billions in revenue, thousands of engineered strains, and large-scale fermentation capacities, while governments worldwide allocate significant fund…
Cabot Corporation CBT has completed the acquisition of Mexico Carbon Manufacturing S.A. de C.V. (MXCB) from Bridgestone Corporation, concluding a transaction announced in August 2025 after securing all necessary regulatory approvals. Cabot…
Century Aluminum Company CENX recently announced the divestment of its Hawesville, KY, facility to TeraWulf Inc., which intends to transform the location into a large-scale digital infrastructure campus focused on high-performance computin…